2019
DOI: 10.1007/978-3-030-31635-8_124
|View full text |Cite
|
Sign up to set email alerts
|

Regulation and Approval of Continuous Non-invasive Blood-Pressure Monitoring Devices

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(6 citation statements)
references
References 25 publications
0
6
0
Order By: Relevance
“…2a-c). Some devices based on PTT or PWA and requiring periodic cuff BP calibrations have some regulatory approval and are already available on the market [31,[46][47][48], yet they are not currently recommended for clinical use [2]. These devices estimate BP changes from the initial cuff calibration BP.…”
Section: Technologies Requiring User Cuff Calibrationmentioning
confidence: 99%
“…2a-c). Some devices based on PTT or PWA and requiring periodic cuff BP calibrations have some regulatory approval and are already available on the market [31,[46][47][48], yet they are not currently recommended for clinical use [2]. These devices estimate BP changes from the initial cuff calibration BP.…”
Section: Technologies Requiring User Cuff Calibrationmentioning
confidence: 99%
“…Form factor: Conversion of smartphones into calibration-free BP monitors would improve hypertension awareness, whereas development of wearables, even with a cuff-calibrated method, is needed for hypotension surveillance in addition to hypertension diagnosis. Evaluation: Compelling evaluation of cuffless methods is a must (5,96,127). For example, machine learning models must show added value over baseline models in which the physiological measurement is excluded as input.…”
Section: Discussionmentioning
confidence: 99%
“…The opportunity for such monitoring is as high as ever due to recent technological advances, including the proliferation of smartphones with sensors therein and unobtrusive wearable sensing. For these two reasons, studies on cuffless BP measurement have been increasingly appearing in the literature, and devices are now emerging in the marketplace (5)(6)(7)(8)(9). Despite considerable advances, the realization of cuffless BP monitoring has proved difficult, and to date, no device or measurement principle has been widely accepted.…”
Section: Introductionmentioning
confidence: 99%
“…Thus, cuffless BP devices are now available on the market and are garnering great interest from doctors, patients, members of the public, and researchers. [5][6][7][8][9][10] It is important to note that these devices are heterogenous in several respects. First, they use different principles and methods for estimating BP.…”
Section: The Emerging Market Of Cuffless Bp Devicesmentioning
confidence: 99%
“…Four regression models were developed to predict systolic BP (SBP) and diastolic BP (DBP) from features of the (1) tonometry and ECG waveforms (eg, similar to the Food and Drug Administration (FDA)-cleared Healthstats and LiveMetric devices 9,10 but also including additional ECG information); (2) PPG and ECG waveforms (eg, similar to the FDA-cleared Sotera device 5 ); (3) PPG waveform (eg, similar to the FDA-cleared Biobeat, CE-marked Aktiia, and South Korea regulator-approved Samsung devices 6–8 ); and (4) ECG waveform alone (Figure 1D; Table 2). The models also considered the time of day, which may help in tracking typical diurnal BP variations (eg, BP is lower at night), and arm posture via the accelerometer (see, for example, the study by Shaltis et al 14 ) as non-waveform features for predicting BP.…”
Section: The Microsoft Research Aurora Project On Assessing the Accur...mentioning
confidence: 99%